Abstract
85P The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on patients with stage I non-small cell lung cancer harboring sensitive EGFR mutations
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have